Quintrio
Home

HOSPITAL & MEDICAL SERVICE PLANS

Trupanion, Inc.

TRUP

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions. Geographically, the company operates in United States, which derives maximum revenue; and Canada and Others.

Last trade $36.69
Day change +$0.525 (+1.45%)
Day range $35.30 – $36.78
Volume 176,280
Market cap $1.56B

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$1.56B
Price / earnings
58.76×
Price / book
3.92×
Price / sales
1×
EV / sales
0.96×
EV / EBITDA
33.9×

Profitability

Earnings per share
$0.62
Return on assets
2.89%
Return on equity
6.67%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.26×
Current ratio
1.74×
Quick ratio
1.74×
Cash ratio
0.42×

Cash flow

Price / cash flow
16.37×
Price / free cash flow
18.04×
Free cash flow
$86.71M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for TRUP, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$405.59M$392.93M$384.05M$376.85M$366.92M$353.56M$341.98M$337.31M
Cost of revenue$336.09M$327.8M$322.56M$311.83M$306.87M$298.73M$290.87M$284.38M
Gross profit$69.5M$65.13M$61.49M$65.03M$60.05M$54.83M$51.1M$52.92M
Selling, general and administrative$43.62M$42.33M$41.71M$41.43M$40.26M$39.97M$40.41M$35.18M
Research and development$12.51M$12.75M$11.29M$11.3M$9.89M$8.59M$8.07M$8.17M
Total operating expenses$59.96M$58.76M$56.71M$56.76M$54.2M$52.51M$52.27M$47.28M
Operating income$9.54M$6.38M$4.78M$8.27M$5.86M$2.31M-$1.17M$5.65M
Interest expense-$1.82M-$1.83M-$1.88M-$4.08M-$2.79M-$3.68M-$3.21M-$3.43M
Income before taxes$10.25M$7.37M$5.96M$6.29M$6.6M$10.55M-$1.44M$1.69M
Income taxes$964K$542K$1.08M$663K$726K$1.13M$39K$38K
Net income$9.28M$6.83M$4.88M$5.63M$5.87M$9.41M-$1.48M$1.66M
Net income attributable to common shareholders$9.28M$6.83M$4.88M$5.63M$5.87M$9.41M-$1.48M$1.66M
EBITDA$13.37M$10.05M$8.48M$12.3M$9.91M$6.28M$2.62M$9.57M
Basic earnings per share$0.21$0.16$0.11$0.13$0.14$0.22-$0.03$0.04
Diluted earnings per share$0.21$0.16$0.11$0.13$0.13$0.22-$0.03$0.04

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Zacks Industry Outlook Highlights Aflac, Unum, Globe, Trupanion and Employers

The Accident & Health Insurance industry faces pricing pressures and rising medical costs, but benefits from increased demand for supplemental health products and technology adoption. Five insurers—Aflac, Unum Group, Globe Life, Trupanion, and Employers Holdings—are highlighted as potential investments despite industry headwinds. The industry carries a Zacks Industry Rank #196 (bottom 21%), though it has outperformed the broader market year-to-date.

Zacks Investment Research

Trupanion (TRUP) Q3 Earnings and Revenues Beat Estimates

Trupanion reported Q3 2026 earnings of $0.21 per share, beating consensus estimates of $0.16, with revenues of $405.59 million slightly exceeding expectations. However, the stock has underperformed the S&P 500 by 22.2% year-to-date. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions. Meanwhile, Oaktree Specialty Lending is expected to report a 15% year-over-year earnings decline when it releases results on November 17.

Zacks Investment Research

Trupanion (TRUP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Trupanion reported Q3 2026 revenue of $405.59 million, up 10.5% year-over-year, beating the consensus estimate of $402.16 million by 0.85%. EPS came in at $0.21, significantly exceeding the estimate of $0.16 by 31.25%. The subscription business revenue grew 13.9% to $287.9 million, while subscription adjusted operating income reached $45.38 million, surpassing analyst expectations. The stock has gained 36.7% over the past month and carries a Zacks Rank #3 (Hold) rating.

Zacks Investment Research

5 Accident & Health Insurers to Watch Despite Cost Pressure

The Accident and Health Insurance industry faces pricing pressures and medical inflation challenges, but benefits from growing demand for supplemental health insurance and technology adoption. Despite outperforming the S&P 500 year-to-date with a 12.2% gain, the industry carries a weak Zacks Industry Rank #196, reflecting negative earnings outlooks. Five stocks are highlighted as potential holdings with mixed growth prospects.

Zacks Investment Research

Aflac (AFL) Surpasses Q3 Earnings and Revenue Estimates

Aflac reported Q3 2026 earnings of $2.43 per share, significantly beating the consensus estimate of $1.80 per share, representing a 35% earnings surprise. Revenue of $4.3 billion also exceeded expectations by 2.21%. However, the stock received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market. The Insurance - Accident and Health industry ranks in the bottom 31% of Zacks industries.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.